SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TITAN PHARMACEUTICAL (TTP)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Czechsinthemail who wrote (231)10/7/2002 1:28:41 PM
From: nigel bates  Read Replies (1) of 362
 
FWIW (reasonable chunk of change) -

WASHINGTON -(Dow Jones)- Titan Pharmaceuticals Inc. (AMEX:TTP - News) Chairman, President and Chief Executive Louis Bucalo bought 200,000 shares of the company's common stock Thursday, according to a Form 4 filed Monday with the Securities and Exchange Commission.
Bucalo bought the shares at a price of $1.51 each. After the transaction, Bucalo directly owned 300,231 Titan Pharmaceuticals common shares.
Titan Pharmaceutical is a biopharmaceutical company that develops therapeutic products for serious diseases such as neurological disorders and various forms of cancer including lung, pancreatic, skin and colorectal.
Monday, shares of the company were down 1 cent to $1.40.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News